Common Stock, par value $0.01 per share
- Symbol
- IEX
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
IDEX Corporation
IEXNYSEEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02 – Results of Operations and Financial Condition. On February 4, 2026, IDEX Corporation (the “Company”) issued a press release announcing financial results for the period ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report.…
Press release in this filing
IDEX REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS Fourth Quarter Highlights →Company context
IDEX Corporation (NYSE: IEX), a global engineered products company, is comprised of three primary business segments - Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety/Diversified Products. Thousands of IDEX employees around the world design and manufacture highly engineered components and applied solutions that are vital to the advances of modern life and help IDEX live its purpose - Trusted Solutions, Improving Lives™. From satellite communications to water systems, from medical diagnostic components to emergency rescue tools and more, we collaborate with customers in the most critical industries to develop solutions that make the world better today and into the future. Founded in 1988, IDEX now includes more than 50 dynamic businesses around the world and manufacturing operations in more than 20 countries.
Current securities
Registered securities in this filing
IDEX CORP · 8-K · Filed 2026-02-04
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02 – Results of Operations and Financial Condition.
On February 4, 2026, IDEX Corporation (the “Company”) issued a press release announcing financial results for the period ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report.
The information contained in this Item 2.02 (including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Filed exhibits (1)
For further information: TRADED: NYSE (IEX) EX-99.1 Investor Contact: Jim Giannakouros, CFA Vice President, Investor Relations (847) 313-9506 IDEX REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS Fourth Quarter Highlights (All comparisons are against the fourth quarter of 2024 unless otherwise noted) • Record sales of $899 million increased 4% on a reported basis and 1% organically • Reported diluted EPS of $1.71 increased 6% and adjusted diluted EPS of $2.10 increased 3% • Record orders of $979 million increased 20% on a reported basis and 16% organically, driven mostly by strength in HST • Utilized $73 million for share repurchases Full Year Highlights (All comparisons are against full year 2024 unless otherwise noted) • Record sales of $3.5 billion increased 6% on a reported basis and 1% organically • Reported diluted EPS of $6.41 decreased 3% and adjusted diluted EPS of $7.95 increased 1% • Operating cash flow of $680 million increased 2% and was 141% of net income, up from 132% • Free cash flow of $617 million increased 2% and yielded conversion of 103%, up from 101% • Utilized $248 million for share repurchases NORTHBROOK, IL, FEBRUARY 4, 2026 - IDEX Corpo…
Open exhibit ↗